+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cephazolin"

Cephalosporin Global Market Report 2024 - Product Thumbnail Image

Cephalosporin Global Market Report 2024

  • Report
  • March 2024
  • 175 Pages
  • Global
From
Cephalosporin Markets in China - Product Thumbnail Image

Cephalosporin Markets in China

  • Report
  • October 2023
  • 270 Pages
  • China
From
Cephalosporin Industry Forecasts - China Focus - Product Thumbnail Image

Cephalosporin Industry Forecasts - China Focus

  • Report
  • October 2023
  • 135 Pages
  • China
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Cephazolin is an antibiotic used to treat a variety of bacterial infections. It belongs to the cephalosporin class of antibiotics, which are derived from the fungus Acremonium. Cephazolin is used to treat infections caused by Gram-positive and Gram-negative bacteria, including skin and soft tissue infections, urinary tract infections, and respiratory tract infections. It is also used to prevent infections in certain surgical procedures. Cephazolin is available in both oral and injectable forms. The cephazolin market is highly competitive, with a number of generic and branded products available. The market is driven by the increasing prevalence of bacterial infections, the rising demand for antibiotics, and the growing number of surgical procedures. The market is also influenced by factors such as the availability of generic drugs, the emergence of new antibiotics, and the increasing use of combination therapies. Some of the major companies in the cephazolin market include Pfizer, Merck, Sanofi, Novartis, and GlaxoSmithKline. Show Less Read more